# DARUNAVIR
> **ANDA206288** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2023-11-28
## Drug
- **FDA Application Number:** ANDA206288
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DARUNAVIR
- **Generic name:** DARUNAVIR
- **Active ingredients:** DARUNAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2023-11-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206288)
---
*AI Analytics · CC0 1.0*